Found 101 matching trials
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia EARLY_PHASE1 The main objective of this study is to observe and evaluate the safety and ...
Show More Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation NA This is an open, one-arm study to evaluate the safety and efficacy of mRNA ...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) PHASE2 The purpose of this study is to assess whether postoperative adjuvant thera...
Show More Status
Active Not Recruiting
Location
University of Arizona
Learn More & Join Trial
Personalized Neoantigen Peptide Vaccines for Solid Tumors PHASE1 This clinical trial is studying the safety and efficacy of a personalized c...
Show More Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Learn More & Join Trial
Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE) PHASE2 In this study, the investigators provide an individualized tumor neoantigen...
Show More Location
University of Hong Kong-Shenzhen Hospital
Learn More & Join Trial
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma PHASE1 This research study is studying the drugs called NeoVax (a new type of pers...
Show More Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC PHASE2 The goal of this clinical trial is as follows:(1) Establish a clinical tech...
Show More Location
Second Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Personalized DC Vaccine for Postoperative Cancer PHASE1 The study is aimed to the test efficacy and safety of neoantigen-primed den...
Show More Learn More & Join Trial
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. PHASE1 This research study is studying a novel type of CLL vaccine as a possible t...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment NA In this study, the investigators provide a combined treatment of personaliz...
Show More Location
First Affiliated Hospital of Nanchang University
Learn More & Join Trial